Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs
(MedPage Today) -- SGLT2 inhibitors were associated with a lower or similar fracture risk compared with incretin-based antidiabetic agents in postmenopausal women with type 2 diabetes, according to a claims-based study involving two independent...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Incretin Therapy | SGLT2 Inhibitors | Study | Women